Astrana Health (ASTH) Outperformed Due to Strong Q2 Performance
Diamond Hill Capital's Small Cap Strategy, a First Eagle Investment Management company, reported strong second-quarter returns of 24.01%, outperforming the Russell 2000 Index by nearly three percentage points. The fund attributed its success largely to stock selection in healthcare and industrials sectors, with Astrana Health (NASDAQ:ASTH) being one notable contributor. Astrana Health, a U.S.-based provider of medical care services, was highlighted for outperforming due to consistent results without exploiting Medicare coding loopholes. The company's balance sheet has improved following the acquisition of Prospect Health and benefited from better-than-expected Medicare Advantage rates. As of September 2, 2026, ASTH closed at $38.57 per share with a market cap of $1.91 billion. The fund emphasized its focus on resilient companies in infrastructure, defense modernization, and essential industries for long-term value creation.
Tickers: $ASTH
Topics: Astrana Health Diamond Hill Capital Q2 performance Small Cap Strategy